logo
April CPI, On Holding earnings, NFIB optimism: What to Watch

April CPI, On Holding earnings, NFIB optimism: What to Watch

Yahoo12-05-2025

Market Domination Overtime co-hosts Julie Hyman and Josh Lipton preview several of the top market and industry stories to come tomorrow, Tuesday, May 13, including earnings from companies like JD.com (JD), Tencent Music Entertainment (TME), and Oklo (OKLO), in addition to April's Consumer Price Index (CPI) report due out in the morning.
To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

UNCF's Institute for Capacity Building Releases Career Pathways Initiative Report to Elevate HBCU Student Success and Career Outcomes
UNCF's Institute for Capacity Building Releases Career Pathways Initiative Report to Elevate HBCU Student Success and Career Outcomes

Business Upturn

timean hour ago

  • Business Upturn

UNCF's Institute for Capacity Building Releases Career Pathways Initiative Report to Elevate HBCU Student Success and Career Outcomes

WASHINGTON, DC, June 05, 2025 (GLOBE NEWSWIRE) — Today, UNCF's Institute for Capacity Building (ICB) released the highly anticipated Career Pathways Initiative (CPI) report, providing a data-driven narrative on how historically Black colleges and universities (HBCUs) are redefining student success and aligning education with career outcomes. Fueled by a grant from Lilly Endowment Inc., CPI is empowering HBCUs to strengthen the link between academic experiences and the demands of a rapidly evolving workforce. The outcomes speak volumes. Across the program period, 2016 to 2022, participating institutions experienced a 27% increase in median job placement and a 21% increase in median salary when comparing pre- and post-pandemic periods. But CPI's impact goes beyond employment metrics. The report reveals CPI is a transformative approach to experiential learning and student engagement. The report highlights a 184% surge in service-learning participation, a 100% increase in undergraduate research experiences, and a 40% growth in internship engagement. 'These numbers reflect more than just programmatic success—they represent lives changed and futures reshaped,' said Ed Smith-Lewis, UNCF's senior vice president of institutional programs and strategic partnerships, who led the initiative. 'This report isn't just a look back; it's a vision forward—a blueprint for how HBCUs can lead in designing bold, student-centered pathways that drive economic mobility.' At the heart of CPI is a three-pronged framework built on a bold, proactive and continuous approach to institutional transformation. This model fosters a deeply collaborative environment between ICB and its institutional partners—one defined by mutual accountability, shared learning, and a commitment to student outcomes. The three strategic pillars include: Guided Pathways: Embedding student success into the core of institutional operations by ensuring every student gets on, stays on, and graduates from a pathway that supports both personal and professional aspirations. Embedding student success into the core of institutional operations by ensuring every student gets on, stays on, and graduates from a pathway that supports both personal and professional aspirations. Integrated Co-Curricular Engagement: Redesigning curricula to streamline academic offerings, embedding 21st century competencies that prepare students for real-world challenges. Redesigning curricula to streamline academic offerings, embedding 21st century competencies that prepare students for real-world challenges. Curricular Enhancements: Expanding co-curricular learning opportunities that increase awareness, exposure and skill development in alignment with workforce needs. In the months ahead, ICB will release a series of companion pieces to the report. They will include case studies that illustrate how HBCUs are using CPI to reimagine advising models, strengthen employer partnerships, and unlock equitable access to high-growth industries. This work is part of ICB's larger mission: to catalyze transformation across the HBCU sector through aligned partnerships, strategic investments, and a commitment to institutional excellence. To read the CPI report visit: UNCF's Institute for Capacity Building Launches Career Pathways Initiative Report to Elevate HBCU Student Success & Career Outcomes – UNCF ICB. ### About UNCF UNCF is one of the nation's largest and most effective supporters of higher education and serves as a leading advocate for college-bound students. Since its founding in 1944, UNCF has raised more than $6 billion to support students' access to higher education, provide scholarships and strengthen historically Black colleges and universities (HBCUs). Each year, UNCF supports more than 50,000 students at more than 1,100 colleges and universities across the country including 37 UNCF-member HBCUs. Through its efforts, UNCF has helped generations of students to get to and through college. We believe a college education plays a vital role in fortifying the pipeline of leaders and professionals who contribute to the advancement of our society. Our logo features the UNCF torch of leadership in education and our widely recognized trademark is, 'A mind is a terrible thing to waste.'® Learn more at or for continuous updates and news, follow UNCF on Instagram. About UNCF's Institute for Capacity Building UNCF's Institute for Capacity Building partners with Black colleges and universities to propel a shared pursuit of student success, community advancement and the fight for racial-justice equity. To learn more about UNCF Institute for Capacity Building, please visit Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.

Circle soars with IPO, Ciena sinks, Planet Labs Q1 beat
Circle soars with IPO, Ciena sinks, Planet Labs Q1 beat

Yahoo

timean hour ago

  • Yahoo

Circle soars with IPO, Ciena sinks, Planet Labs Q1 beat

Market Domination co-host Julie Hyman tracks today's top moving stocks and biggest market stories in this Market Minute. Circle Internet Group (CRCL) soars after the stablecoin issuer debuted on the NYSE, signaling strong investor demand for crypto assets. Ciena (CIEN) stock drops as the network gear maker posts a first quarter earnings miss, with rising operating expenses and disappointing gross margins. Meanwhile, Planet Labs (PL) shares jumped after beating first quarter revenue estimates. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute. It's time for Yahoo! Finance's market minute. Stocks seesawing as investors weigh President Trump's talk with Chinese President Xi and also Trump's altercation with Tesla CEO Elon Musk. The S&P 500 eyeing breaching the 6,000 level for the first time since February. Stablecoin issuer Circle going public on the New York Stock Exchange, the stock opening at $69 after pricing its IPO at $31 per share. Those shares are now surging, signaling a healthy appetite for stable coins and for crypto generally. Ciena stock sinking after the maker of network gear posting an earnings miss, the company reporting a rise in operating expenses in the first quarter and also gross margin falling short of analyst estimates. And shares of Planet Labs surging after the satellite data provider topping first quarter revenue expectations. Wedbush highlighting that the quarter was a step in the right direction, adding that the company finds itself at the center of multiple market-changing transformations. And that's your Yahoo! Finance market minute.

MAIA Biotechnology's Experimental Cancer Drug Shows Tripled Survival Vs. Standard Chemotherapy In Pretreated Lung Cancer Patients
MAIA Biotechnology's Experimental Cancer Drug Shows Tripled Survival Vs. Standard Chemotherapy In Pretreated Lung Cancer Patients

Yahoo

timean hour ago

  • Yahoo

MAIA Biotechnology's Experimental Cancer Drug Shows Tripled Survival Vs. Standard Chemotherapy In Pretreated Lung Cancer Patients

MAIA Biotechnology, Inc. (NASDAQ:MAIA) on Thursday revealed updated data from its THIO-101 pivotal Phase 2 clinical trial. The trial is evaluating its lead clinical candidate, ateganosine (THIO), sequenced with Regeneron Pharmaceutical Inc's (NASDAQ:REGN) immune checkpoint inhibitor (CPI) cemiplimab (Libtayo) for advanced non-small cell lung cancer (NSCLC) who are resistant to immune therapy and chemotherapy. As of May 15, third line (3L) data showed median overall survival (OS) of 17.8 months for the 22 NSCLC patients who received at least one dose of ateganosine (the intent-to-treat population) in parts A and B of the trial. The updated analysis demonstrates a 95% confidence interval (CI) lower bound of 12.5 months and a 99% CI lower bound of 10.8 treatment has been generally well-tolerated to date in this heavily pretreated population. At the data cutoff, the patient with the longest survival in the trial had completed 32 cycles of therapy and had 24.3 months survival. Studies of standard-of-care (SOC) chemotherapy treatments for NSCLC in a similar setting have shown OS of 5 to 6 months. 'This new benchmark of 17.8 months median OS is nearly triple the recognized SOC data for third-line NSCLC found in the medical literature. We believe this is a substantial indicator of the potential ateganosine has to shift the NSCLC treatment landscape,' said MAIA Chairman and CEO Vlad Vitoc. MAIA's multiple potential regulatory pathways for ateganosine could provide accelerated FDA approval and robust exclusivity in NSCLC, with a potential FDA decision as early as next year. The company announced a new partial response (PR) was identified in a patient after 20 months of treatment. A partial response is defined as a decrease in tumor size of at least 30%. 'The patient remained on treatment and we observed stable disease for more than twenty months before the partial response was identified, highlighting the efficacy, safety and low toxicity of the treatment,' Vitoc added. Price Action: MAIA stock is up 11.7% at $1.97 at the last check on Thursday. Read Next:Photo via Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? This article MAIA Biotechnology's Experimental Cancer Drug Shows Tripled Survival Vs. Standard Chemotherapy In Pretreated Lung Cancer Patients originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store